Hiatus Urogenitalis and its Dorsal Component;Importance for Continence of Urine and Stools in Women
Authors:
M. Krčmář 1; M. Otčenášek 1; M. Halaška 1; D. Kolařík 1; J. Záhumenský 1; Michael Jiří Halaška 2
Authors‘ workplace:
Gynekologicko-porodnická klinika 1. LF UK, FN Bulovka, Praha, přednosta prof. MUDr. M. Halaška, DrSc. 2Gynekologicko-porodnická klinika 2. LF UK, FN Motol, Praha, přednosta doc. MUDr. L. Rob, CSc.
1
Published in:
Ceska Gynekol 2004; (2): 140-148
Category:
Overview
Objective:
Numerous anatomical studies over the last years resulted in a principal shift in theview of the area of female pelvic fl oor. These studies also deal with the area of posterior compartment,i.e. a region which used to be of little interest to urogynecologists. This article presentsa brief outline of anatomical and physiological knowledge as well as a brief survey of most importantmethods of examination and basic clinical symptoms associated with disorders of posteriorpart of hiatus urogenitalis. The presently accepted concept of a complex approach to disorders offemale pelvic fl oor will probably require increased interest in this area among urogynecologists.The article is aimed at summarizing elementary knowledge necessary for adequate clinical care připoofpatients suffering from disorder in posterior compartment function.Subject: Review article.Setting: Department of Gynecology and Obstetric, Faculty Hospital Na Bulovce, 1st Medical Faculty,Prague, Czech Republic
Key words:
pelvic fl oor, posterior compartment
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2004 Issue 2
Most read in this issue
- The Prophylactic Adnexectomy
- Screening of Hemolytical Streptococcus of Group B inPregnancy and Prevention of Infection in Newborns
- Hiatus Urogenitalis and its Dorsal Component;Importance for Continence of Urine and Stools in Women
- A Comparison of the Cost of Treatment with Atosiban orbeta-Sympatomimetic Drugs in Premature Delivery from thePerspective of Health Care Payer – a Pharmaco-Economic Model